JP2025507472A5 - - Google Patents

Info

Publication number
JP2025507472A5
JP2025507472A5 JP2023580943A JP2023580943A JP2025507472A5 JP 2025507472 A5 JP2025507472 A5 JP 2025507472A5 JP 2023580943 A JP2023580943 A JP 2023580943A JP 2023580943 A JP2023580943 A JP 2023580943A JP 2025507472 A5 JP2025507472 A5 JP 2025507472A5
Authority
JP
Japan
Application number
JP2023580943A
Other languages
Japanese (ja)
Other versions
JP2025507472A (ja
JPWO2023165334A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/076078 external-priority patent/WO2023165334A1/zh
Publication of JP2025507472A publication Critical patent/JP2025507472A/ja
Publication of JP2025507472A5 publication Critical patent/JP2025507472A5/ja
Publication of JPWO2023165334A5 publication Critical patent/JPWO2023165334A5/ja
Pending legal-status Critical Current

Links

JP2023580943A 2022-03-01 2023-02-15 ケトアミド系誘導体及びその製薬における使用 Pending JP2025507472A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202210199543.5 2022-03-01
CN202210199543 2022-03-01
PCT/CN2023/076078 WO2023165334A1 (zh) 2022-03-01 2023-02-15 酮酰胺类衍生物及其制药用途

Publications (3)

Publication Number Publication Date
JP2025507472A JP2025507472A (ja) 2025-03-21
JP2025507472A5 true JP2025507472A5 (https=) 2025-12-17
JPWO2023165334A5 JPWO2023165334A5 (https=) 2025-12-17

Family

ID=87830006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023580943A Pending JP2025507472A (ja) 2022-03-01 2023-02-15 ケトアミド系誘導体及びその製薬における使用

Country Status (5)

Country Link
US (1) US20250064789A1 (https=)
EP (1) EP4488264A4 (https=)
JP (1) JP2025507472A (https=)
CN (1) CN116693447B (https=)
WO (1) WO2023165334A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024525589A (ja) 2021-07-09 2024-07-12 アリゴス セラピューティクス インコーポレイテッド 抗ウイルス化合物
EP4488264A4 (en) * 2022-03-01 2026-03-04 Westvac Biopharma Co Ltd CETO AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09500087A (ja) * 1992-06-24 1997-01-07 コーテックス ファーマシューティカルズ インコーポレイテッド カルパイン活性の増大に関連した健康障害の抑制及び処置におけるカルパイン阻害剤の使用法
US5514694A (en) * 1992-09-21 1996-05-07 Georgia Tech Research Corp Peptidyl ketoamides
JPH08208462A (ja) * 1994-11-24 1996-08-13 Takeda Chem Ind Ltd カテプシンl阻害剤
US6303579B1 (en) * 1996-10-31 2001-10-16 Alcon Laboratories, Inc. Use of calpain inhibitors to treat ocular neural pathology
CN1306526A (zh) * 1998-04-20 2001-08-01 Basf公司 具有半胱氨酸蛋白酶抑制作用的新的杂环取代酰胺
AU2002232558A1 (en) * 2000-12-12 2002-06-24 Corvas International, Inc. Compounds, compositions and methods for treatment of parasitic infections
JP2006503069A (ja) * 2002-09-25 2006-01-26 ジョージア テック リサーチ コーポレイション 慢性神経疾患におけるケトアミド阻害剤
US8236798B2 (en) * 2009-05-07 2012-08-07 Abbott Gmbh & Co. Kg Carboxamide compounds and their use as calpain inhibitors
US8598211B2 (en) * 2009-12-22 2013-12-03 Abbvie Inc. Carboxamide compounds and their use as calpain inhibitors IV
GB201001070D0 (en) * 2010-01-22 2010-03-10 St George's Hospital Medical School Theraputic compounds and their use
BR112019006110A2 (pt) * 2016-09-28 2019-09-10 Blade Therapeutics Inc moduladores de calpaína e usos terapêuticos dos mesmos
CN115698035A (zh) * 2020-04-10 2023-02-03 共晶制药公司 诺如病毒及冠状病毒复制的抑制剂
PH12022553378A1 (en) * 2020-06-10 2024-03-25 Univ Leuven Kath Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CN115960088B (zh) * 2020-07-31 2024-07-26 四川大学 一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途
CN114057702B (zh) * 2020-07-31 2022-09-30 四川大学 一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途
US20240083885A1 (en) * 2020-12-04 2024-03-14 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for inhibiting m pro protease activity and for preventing and treating sars-cov-2 infection
WO2022265577A2 (en) * 2021-06-15 2022-12-22 Agency For Science, Technology And Research Coronavirus enzyme modulators, methods of synthesis and uses thereof
JP2023000996A (ja) * 2021-06-18 2023-01-04 ラクオリア創薬株式会社 プロテアーゼ阻害剤としてのケトアミド誘導体
EP4488264A4 (en) * 2022-03-01 2026-03-04 Westvac Biopharma Co Ltd CETO AMIDE DERIVATIVES AND THEIR PHARMACEUTICAL USE

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13176U (https=)
BY13145U (https=)
BY13174U (https=)